Mr. Huang manages his diabetes with his lifestyle modifications, metformin, and linagliptin, and returns every 6 months for follow-up visits. Three years after initiating this treatment plan, he returns to your clinic for his 6-month check-up. When asked how his diabetes management is going at home, he shares that recently he has been “unable to really get out and get as much exercise as he knows he should due to his creaky, old knees acting up.” His current office A1C is 8.8%. You discuss with him what the next management steps may be to achieve his individualized glycemic goal. What would your next medical management step be? A. Add a rapid-acting insulin analogue B. Add a long-acting insulin analogue C. Add a GLP-1 agonist D. Add a sulfonylurea Follow the link for the answer.

Scarce data on new glucose-lowering agents, with high risk for bias toward negative outcomes

The American Diabetes Association’s 78th Scientific SessionsThe annual meeting of the American Diabetes Association (ADA) was held from June 22 to 26 in Orlando, Florida, and attracted approximately 14,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest …

No interactions seen for any outcome; log-additive effect on risk of developing cardiovascular disease

Eversense CGM, which has fully implantable sensor to detect glucose, approved for adults with diabetes

Patterns of use, timing of hospice similar among patients with diverse spending trajectories

Findings based on one-year follow-up in teens with type 1 diabetes participating in the STePS study

Joy and Steve just returned from the ADA Scientific Sessions in Orlando, and over the next few weeks, you will have the chance to find out what they and our other reporters learned. For a little teaser, our Medical Editor, Joy Pape, shares her experiences with the recommendation and use …

What I love about going to conferences is the realization that what I’m doing in my practice is in line with what others I respect are doing. That is meaningful, and I always learn a new pearl. If that’s all I gain from these conferences, it’s okay, but it’s usually more than that. I have just returned from the 2018 ADA Conference, where there was so much about new technology, particularly continuous glucose monitoring.

Scott Kahan, MD, MPH is the Director of the National Center for Weight and Wellness. He is a physician trained in both clinical medicine and public health. He serves on the faculties of the Johns Hopkins Bloomberg School of Public Health, the George Washington University School of Medicine, and the George Washington University School of Public Health and Health Services.